Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.290
-0.040 (-3.01%)
Mar 20, 2026, 4:00 PM EDT - Market closed
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $79.87 million as of March 20, 2026. Its market cap has decreased by -17.45% in one year.
Market Cap
79.87M
Enterprise Value
-81.97M
1-Year Change
-17.45%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $79.87M, a decrease of -89.17%. That is a compound annual growth rate of -31.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 79.87M | 6.54% |
| Dec 31, 2025 | 74.97M | -90.65% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vivani Medical | 84.62M |
| Impact BioMedical | 84.10M |
| Kazia Therapeutics | 81.50M |
| Seres Therapeutics | 81.48M |
| Champions Oncology | 81.38M |
| Biomea Fusion | 80.60M |
| Spruce Biosciences | 80.13M |
| aTyr Pharma | 79.25M |